Jones Allen R Jr.
Known title: DirectorCIK: 0001868983
Jones Allen R Jr.'s purchase track record
How the stock did after each of Jones Allen R Jr.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since December 14, 2022
Stock higher 6 months later
0%
3 months: 0%
Median 6-month return
-17.5%
3 months: -18.1%
Beat the S&P 500
0%
median -29.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/15/2023 | FRST | $45K | -18.1% | -14.9% | +14.8% |
| 2/7/2023 | FRST | $25K | -39.3% | -17.5% | +8.1% |
| 12/14/2022 | FRST | $20K | -15.7% | -31.0% | +9.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| FRST | ▲ Buy | Open Market | 2,537 | $25K | 3/15/2023 | View on chart |
| FRST | ▲ Buy | Open Market | 2,055 | $20K | 3/15/2023 | View on chart |
| FRST | ▲ Buy | Open Market | 2,019 | $25K | 2/7/2023 | View on chart |
| FRST | ▲ Buy | Open Market | 1,600 | $20K | 12/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Raymond James Cuts Primis Financial Target to $18
Raymond James maintained its Strong Buy rating on Primis Financial Corp. but lowered its price target to $18. This adjustment aligns with the current analyst consensus, where the average target is $18.94. The stock is currently trading near its support level, reflecting a cautious market stance despite the firm's positive outlook.
Raymond James Cuts Primis Financial Target to $18. Raymond James maintained its Strong Buy rating on Primis Financial Corp. but lowered its price target to $18. This adjustment aligns with the current analyst consensus, where the average target is $18.94. The stock is currently trading near its support level, reflecting a cautious market stance despite the firm's positive outlook.